Search results
What Is Ulcerative Colitis?
Verywell Health via Yahoo News· 1 year agoUlcerative colitis (UC) is a type of inflammatory bowel disease (IBD) that primarily affects the large intestine (colon). There is currently no cure for...
Is Ulcerative Colitis an Autoimmune Disease?
Verywell Health via Yahoo News· 3 months agoMedically reviewed by Jay N. Yepuri, MD Ulcerative colitis is a type of inflammatory bowel disease (IBD). A problem with the immune system leads to...
Is Ulcerative Colitis Curable, or Is Symptom Remission Possible?
Verywell Health via Yahoo News· 6 months agoUlcerative colitis (UC) is a chronic inflammatory bowel disease (IBD). There is no known cure for...
Pfizer Has a New Oral Pill for Ulcerative Colitis
Verywell Health via Yahoo News· 6 months agoThe FDA approved Velsipity (etrasimod), a drug by Pfizer to treat ulcerative colitis. The approval adds another treatment option for patients who respond...
How Is Ulcerative Colitis Treated?
Health via Yahoo News· 2 weeks agoMaca and Naca / Getty Images Medically reviewed by Jay N. Yepuri, MD Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD) that affects the large intestine. Inflammation in the ...
The Surprise That Prompted Morphic Therapeutic To Dump 55% Over Two Days
Investor's Business Daily· 7 months agoMorphic Therapeutic stock plummeted Monday after tests showed the company's ulcerative colitis drug...
Takeda Pharmaceutical: A Long-Term Cash Cow
GuruFocus.com via Yahoo Finance· 2 weeks agoTakeda Pharmaceutical Co. Ltd. (NYSE:TAK) is the largest Japanese pharmaceutical company and holds a leading position in the global immunoglobulins...
What to Know About Pouchitis
Verywell Health via Yahoo News· 6 months agoPouchitis is an inflammation that occurs in some people who have had ileal pouch-anal anastomosis (IPAA) surgery. The surgery is often used to treat...
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q2 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 months agoTakeda Pharmaceutical Company Limited (NYSE:TAK) Q2 2023 Earnings Call Transcript October 27, 2023...
FDA Approves First Oral Treatment For Crohn's Disease, Making Seventh Approval For AbbVie's Rinvoq
Benzinga via Yahoo Finance· 12 months agoThe FDA approved AbbVie Inc's (NASDAQ: ABBV) Rinvoq (upadacitinib) for moderately to severely active...